DisclosurePeptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

The compound database

Peptide Databasepage 2

264 therapeutic peptides with research summaries, clinical findings, and regulatory status. Every claim is cited.

FDA-approved
90
FDA-approved
Awaiting FDA
8
Awaiting FDA
No lawful pathway
166
No lawful pathway
37–72 of 264
  1. 037

    Semax

    A synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) that combines the ACTH(4-7) fragment with a stabilizing Pro-Gly-Pro tail and is described as an analog…

    Cognitive · Investigational · Intranasal

    Awaiting FDA
  2. 038

    Selank

    A synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) built from the endogenous tetrapeptide tuftsin with an added Pro-Gly-Pro sequence for stability. In…

    Cognitive · Investigational · Intranasal

    Awaiting FDA
  3. 039

    Cerebrolysin

    A porcine brain-derived preparation of low-molecular-weight peptides and amino acids with proposed neurotrophic and neuroprotective properties. In transgenic…

    Cognitive · In Clinical Trials · Intravenous, Intramuscular injection

    No lawful pathway
  4. 040

    P21 (Peptide)

    A small synthetic peptide (P021) derived from the most active region of ciliary neurotrophic factor (CNTF), with an adamantylated glycine added to improve…

    Cognitive · Research Phase · Subcutaneous injection, Intranasal

    No lawful pathway
  5. 041

    Epithalon (Epitalon)

    A synthetic tetrapeptide (Ala-Glu-Asp-Gly) designed from the amino acid composition of epithalamin, a peptide extract of the pineal gland. In cell culture…

    Longevity · Investigational · Subcutaneous injection, Intravenous

    No lawful pathway
  6. 042

    MOTS-c

    A 16-amino acid mitochondrial-derived peptide encoded by a short open reading frame in the 12S rRNA gene of mitochondrial DNA. In mice and cells, MOTS-c…

    Longevity · Research Phase · Subcutaneous injection

    No lawful pathway
  7. 043

    Humanin

    A 24-amino acid mitochondrial-derived peptide whose coding sequence is nearly identical to a region of the mitochondrial 16S rRNA gene. Humanin acts as a…

    Longevity · Research Phase · Subcutaneous injection, Intravenous

    No lawful pathway
  8. 044

    NAD+ Precursors (NMN)

    Nicotinamide mononucleotide (NMN) is a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular metabolism…

    Longevity · In Clinical Trials · Oral, Intravenous, Sublingual

    No lawful pathway
  9. 045

    SS-31 (Elamipretide)

    A mitochondria-targeted tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH2) that selectively binds cardiolipin in the inner mitochondrial membrane. In laboratory…

    Longevity · FDA Approved · Subcutaneous injection, Intravenous

    FDA-approved
  10. 046

    FOXO4-DRI

    A D-retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells. FOXO4 helps senescent cells avoid apoptosis by binding…

    Longevity · Research Phase · Subcutaneous injection, Intravenous

    No lawful pathway
  11. 047

    Thymalin

    A peptide bioregulator extracted from bovine thymus, consisting of a polypeptide complex that regulates immune function. Thymalin increases the functional…

    Immune · Investigational · Intramuscular injection

    No lawful pathway
  12. 048

    LL-37

    The only human cathelicidin antimicrobial peptide, a 37-amino acid cationic peptide cleaved from the precursor protein hCAP18. LL-37 has broad antimicrobial…

    Immune · Investigational · Subcutaneous injection, Topical

    No lawful pathway
  13. 049

    VIP (Vasoactive Intestinal Peptide)

    A 28-amino acid neuropeptide widely distributed in the central and peripheral nervous systems and immune cells. VIP acts through VPAC1 and VPAC2 receptors and…

    Immune · Investigational · Intranasal, Intravenous, Subcutaneous injection

    No lawful pathway
  14. 050

    Thymosin Alpha 1 (Zadaxin)

    A 28-amino acid peptide originally isolated from thymic tissue (thymosin fraction 5) and used as an immunomodulator under the name thymalfasin. Thymosin alpha…

    Immune · In Clinical Trials · Subcutaneous injection

    Awaiting FDA
  15. 051

    Thymopentin (TP-5)

    A synthetic pentapeptide (Arg-Lys-Asp-Val-Tyr) corresponding to residues 32-36 of thymopoietin, a thymic hormone involved in T-cell differentiation.…

    Immune · Investigational · Subcutaneous injection, Intramuscular injection

    No lawful pathway
  16. 052

    Thymulin

    A zinc-containing nonapeptide (facteur thymique serique) produced exclusively by thymic epithelial cells, whose biological activity depends on bound zinc.…

    Immune · Research Phase · Subcutaneous injection, Intranasal

    No lawful pathway
  17. 053

    KPV

    A C-terminal tripeptide fragment (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone that retains anti-inflammatory activity without melanogenic effects. In…

    Immune · Research Phase · Oral, Topical, Subcutaneous injection

    No lawful pathway
  18. 054

    Enfuvirtide (Fuzeon)

    A 36-amino acid synthetic peptide that inhibits HIV-1 entry into CD4+ T-cells by blocking gp41-mediated membrane fusion. Enfuvirtide binds the first heptad…

    Antimicrobial · FDA Approved · Subcutaneous injection (twice daily)

    FDA-approved
  19. 055

    Melanotan II

    A synthetic cyclic analog of alpha-melanocyte stimulating hormone (alpha-MSH) that non-selectively activates melanocortin receptors. Through MC1R it stimulates…

    Performance · Investigational · Subcutaneous injection

    No lawful pathway
  20. 056

    Teriparatide (Forteo)

    A recombinant form of the first 34 amino acids of human parathyroid hormone (PTH 1-34). When given intermittently by daily subcutaneous injection, teriparatide…

    Bone · FDA Approved · Subcutaneous injection (daily)

    FDA-approved
  21. 057

    Abaloparatide (Tymlos)

    A synthetic 34-amino acid peptide analog of parathyroid hormone-related protein (PTHrP 1-34). In cell studies abaloparatide binds more selectively than PTH…

    Bone · FDA Approved · Subcutaneous injection (daily)

    FDA-approved
  22. 058

    Calcitonin

    A 32-amino acid peptide hormone naturally produced by the parafollicular C-cells of the thyroid gland. Calcitonin inhibits osteoclast activity, reducing bone…

    Bone · FDA Approved · Intranasal, Subcutaneous injection, Intramuscular injection

    FDA-approved
  23. 059

    Vosoritide (Voxzogo)

    A C-type natriuretic peptide (CNP) analog that acts as an agonist at natriuretic peptide receptor B (NPR-B) on growth plate chondrocytes. Achondroplasia is…

    Bone · FDA Approved · Subcutaneous injection (daily)

    FDA-approved
  24. 060

    Vasopressin (ADH)

    A nine-amino acid cyclic peptide hormone (arginine vasopressin) produced in the hypothalamus and released from the posterior pituitary. Vasopressin acts on V1a…

    Renal · FDA Approved · Intravenous, Intramuscular injection, Subcutaneous injection

    FDA-approved
  25. 061

    Desmopressin (DDAVP)

    A synthetic analog of vasopressin (1-deamino-8-D-arginine vasopressin) with selective V2 receptor activity and minimal vasopressor activity. The deamination at…

    Renal · FDA Approved · Intranasal, Oral, Subcutaneous injection, Intravenous

    FDA-approved
  26. 062

    Terlipressin

    A synthetic vasopressin analog and prodrug that is converted in the body to lysine-vasopressin. Terlipressin acts mainly on V1 receptors to constrict…

    Renal · FDA Approved · Intravenous

    FDA-approved
  27. 063

    Eptifibatide (Integrilin)

    A synthetic cyclic heptapeptide modeled on barbourin, a disintegrin from the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri) that…

    Cardiovascular · FDA Approved · Intravenous

    FDA-approved
  28. 064

    Nesiritide (Natrecor)

    A recombinant form of human B-type natriuretic peptide (BNP), a 32-amino acid peptide produced by ventricular cardiomyocytes in response to volume overload and…

    Cardiovascular · FDA Approved · Intravenous

    FDA-approved
  29. 065

    Angiotensin II (Giapreza)

    A synthetic form of the endogenous octapeptide angiotensin II, the main effector of the renin-angiotensin system. Angiotensin II acts on AT1 receptors on…

    Cardiovascular · FDA Approved · Intravenous

    FDA-approved
  30. 066

    Bivalirudin (Angiomax)

    A synthetic 20-amino acid peptide analog of hirudin that acts as a specific, reversible direct thrombin inhibitor, binding both fluid-phase and clot-bound…

    Hematology · FDA Approved · Intravenous

    FDA-approved
  31. 067

    Romiplostim (Nplate)

    A thrombopoietin (TPO) receptor agonist built as a peptibody: TPO-mimetic peptides fused to the Fc portion of human IgG1. It has a similar mechanism of action…

    Hematology · FDA Approved · Subcutaneous injection (weekly)

    FDA-approved
  32. 068

    Pegcetacoplan (Empaveli)

    A pegylated cyclic peptide that inhibits complement component C3 and C3b, acting upstream of C5 in the complement cascade. Because C5 inhibitors control…

    Hematology · FDA Approved · Subcutaneous infusion

    FDA-approved
  33. 069

    Carfilzomib (Kyprolis)

    A tetrapeptide epoxyketone proteasome inhibitor that binds the proteasome irreversibly, with minimal off-target inhibition of other proteases in preclinical…

    Oncology · FDA Approved · Intravenous

    FDA-approved
  34. 070

    Bortezomib (Velcade)

    A dipeptidyl boronic acid that selectively and reversibly inhibits the 26S proteasome, disrupting the ubiquitin-proteasome pathway that degrades many…

    Oncology · FDA Approved · Subcutaneous injection, Intravenous

    FDA-approved
  35. 071

    Lutetium-177 dotatate (Lutathera)

    A radiolabeled somatostatin analog consisting of the peptide DOTA-Tyr3-octreotate chelated to the beta-emitting radioisotope lutetium-177. It binds…

    Oncology · FDA Approved · Intravenous

    FDA-approved
  36. 072

    Leuprolide (Lupron) - Oncology

    A GnRH agonist used in oncology for androgen deprivation therapy (ADT) in prostate cancer. Continuous administration downregulates pituitary GnRH receptors…

    Oncology · FDA Approved · Intramuscular injection (depot), Subcutaneous injection

    FDA-approved

Index · all 264 peptides, A–Z

Important Medical Disclaimer

The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.

Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association checks each clinician’s NPI record but does not employ or directly supervise these clinicians.

© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. The Peptide Association is not a medical practice.